Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Reports
  • Newsletter
  • Methodology
  • Origins
  • Vocab
services
  • Research Sessions
  • Signals Workspace
  • Bespoke Projects
  • Use Cases
  • Signal Scanfree
  • Readinessfree
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
audiences
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Pricing
  • Partners
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
  • Login
ResearchServicesPricingPartnersAbout
ResearchServicesPricingPartnersAbout
  1. Home
  2. Research
  3. DataTrends
  4. Genomics and Big Data Analytics

Genomics and Big Data Analytics

Processing massive genetic datasets to enable personalized medicine and disease prediction
Back to DataTrendsView interactive version

Genomics generates enormous datasets that require sophisticated big data analytics to process, analyze, and derive insights. Beyond traditional spreadsheet approaches, genomics analytics uses distributed computing, machine learning, and cloud platforms to analyze genetic sequences, identify variants, and understand relationships between genetics and health outcomes. The field combines biology, statistics, and computer science to extract knowledge from genetic data.

Applications include personalized medicine based on genetic profiles, disease risk prediction, drug discovery, and population genetics research. Organizations are analyzing genomic data to understand genetic contributions to diseases, develop targeted therapies, and advance precision medicine. The analytics enables moving beyond one-size-fits-all medicine to treatments tailored to individual genetic makeup.

At the Incremental Innovation to Sustaining Performance stage, genomics big data analytics is deployed by research institutions, biotech companies, and healthcare organizations globally. The field is advancing with better algorithms, more affordable sequencing, and improved data infrastructure. Challenges include managing massive data volumes, ensuring privacy of sensitive genetic information, and addressing ethical questions about genetic data usage and discrimination.

Innovation Stage
4/6Incremental Innovation
Implementation Complexity
3/3High Complexity
Urgency for Competitiveness
3/3Long-term
Category
Analytics in Action

Related Organizations

Broad Institute of MIT and Harvard logo
Broad Institute of MIT and Harvard

United States · Research Lab

95%

A biomedical and genomic research center that holds key patents for the use of CRISPR-Cas9 in eukaryotic cells.

Researcher
Illumina logo
Illumina

United States · Company

95%

The dominant provider of DNA sequencing technology.

Developer
DNAnexus logo
DNAnexus

United States · Company

90%

Cloud-based biomedical informatics platform.

Developer
Genomics England logo
Genomics England

United Kingdom · Government Agency

90%

A UK government-owned company running the 100,000 Genomes Project to integrate genomic sequencing into standard NHS care.

Deployer
Tempus logo
Tempus

United States · Company

90%

A technology company advancing precision medicine through the practical application of artificial intelligence in healthcare and genomic profiling.

Deployer
23andMe logo
23andMe

United States · Company

85%

Consumer genetics company holding massive databases of biological profiles.

Deployer
BGI Group logo
BGI Group

China · Company

85%

One of the world's largest genome sequencing centers, providing comprehensive sequencing and bioinformatics services.

Deployer
Fabric Genomics logo
Fabric Genomics

United States · Company

85%

Provides AI-driven interpretation software for clinical genomics, helping clinicians diagnose genetic diseases.

Developer
NVIDIA logo
NVIDIA

United States · Company

85%

Developing foundation models for robotics (Project GR00T) and vision-language models like VILA.

Developer
Oxford Nanopore Technologies logo
Oxford Nanopore Technologies

United Kingdom · Company

85%

Develops portable DNA/RNA sequencing devices used for real-time pathogen surveillance.

Developer
Seven Bridges logo
Seven Bridges

United States · Company

85%

A biomedical data analysis company (acquired by Velsera) that builds cloud platforms for drug discovery and precision medicine.

Developer
Databricks logo
Databricks

United States · Company

80%

Developed DBRX, an open, general-purpose LLM built with a fine-grained Mixture-of-Experts architecture.

Developer

Supporting Evidence

Evidence data is not available for this technology yet.

Connections

Analytics in Action
Analytics in Action
Healthcare Predictive Analytics

Analyzing patient data to forecast disease outbreaks and optimize hospital resources

Innovation Stage
2/6
Implementation Complexity
2/3
Urgency for Competitiveness
1/3
Management Foundations
Management Foundations
Healthcare Data Privacy Analytics

Privacy-preserving techniques that enable clinical insights while maintaining patient confidentiality and regulatory com

Innovation Stage
5/6
Implementation Complexity
3/3
Urgency for Competitiveness
2/3

Book a research session

Bring this signal into a focused decision sprint with analyst-led framing and synthesis.
Research Sessions